Renub Research has recently released a report titled " Multiple Myeloma Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" providing a detailed industry analysis that includes market share insights. In addition, the report covers research on competitors and regions and current advancements in the multiple myeloma market. The Multiple Myeloma Industry shall experience a CAGR of nearly 6.04% from 2023 to 2028. The increasing prevalence of multiple myeloma is aiding the rise of the multiple myeloma market.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/multiple-myeloma-market-p.php
American Society of Clinical Oncology (ASCO) projects that approximately 35,730 adults in the United States, comprising 19,860 men and 15,870 women, will receive a multiple myeloma diagnosis in 2023, with an estimated 12,590 deaths, including 7,000 men and 5,590 women, resulting
